Uncertainty over cost definitions alters CE results

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.590, 2009-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US

By Tunis Sandra L.

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 735-744

Adis International

Access to resources Recommend Favorite

Handling Uncertainty in Cost-Effectiveness Models

By Briggs A.H.

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 479-500

Adis International

Access to resources Recommend Favorite

Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite

Bupropion cost advantage over NRT

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Paracalcitol: cost benefits over calcitriol

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite